India's diabetes burden is escalating rapidly, with 101 million adults currently living with T2DM (ICMR-INDIAB Study)1. Compounding this crisis, MASLD-strongly associated with T2DM and ...

India bears a disproportionate share of the global diabetes burden, with 89.8 million adults living with T2DM against a ...

Researchers analyzed large real-world datasets to evaluate statin therapy across underrepresented patient groups. Their studies confirmed that statins lower cardiovascular risk without increasing ...

A multidisciplinary team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed), has conducted a series of landmark studies demonstrating that statins can lower the risk of ...

Objectives To evaluate whether type 2 diabetes mellitus (T2DM) presence and severity are associated with differences in global and domain-specific cognitive function among US adults, using ...

Background Metabolic-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease affecting approximately ...

Objective To estimate the prevalence of potential overtreatment of type 2 diabetes mellitus (T2DM) among older adults and to develop and compare predictive models to identify patient and physician ...

Physical activity programmes such as the NSC can help mitigate rising obesity and T2DM prevalence when implemented at the population level, as seen in Singapore. However, their success depends on ...

Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted ...

US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Stage II and III ...